How Much Does Melanotan 1 (MT1) Cost in 2026? Pricing Breakdown

Key Takeaways

• Melanotan 1 (MT1) is not FDA-approved and is available only for research purposes, affecting availability and cost information.
• Typical costs are not applicable in the US due to its research-only status.
• Insurance coverage is unlikely since MT1 is not FDA-approved for therapeutic use.
• HSA/FSA eligibility is generally not applicable for non-FDA-approved peptides.
• Cost reduction strategies include exploring legal alternatives and consulting with healthcare providers.

What Is Melanotan 1 (MT1)?

Melanotan 1 (MT1) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) primarily used in research settings to study melanocortin receptor activation. It plays a role in pigmentation and photoprotective pathways. For more detailed information, visit the Melanotan 1 (MT1) profile.

Typical Cost Ranges

As of 2026, Melanotan 1 (MT1) is not FDA-approved for therapeutic use and is available only for research purposes. Consequently, it is not legally sold for personal use in the United States, rendering specific cost information inapplicable. Researchers interested in MT1 must obtain it through authorized channels for scientific study, where pricing can vary based on supplier and quantity.

Insurance Coverage

Given its status as a research-only peptide, Melanotan 1 (MT1) is not covered by insurance for therapeutic purposes. Insurance companies typically require FDA approval for coverage, and MT1 does not meet this criterion. Patients seeking peptide therapies that are FDA-approved may find better insurance support.

HSA/FSA Eligibility

Melanotan 1 (MT1) does not qualify for HSA/FSA spending due to its non-FDA-approved status. These accounts generally cover treatments and medications that are recognized by the FDA for therapeutic use. Patients should consult with their HSA/FSA provider for clarification on eligible expenses.

Telehealth vs. In-Person Pricing

While telehealth services have become popular for delivering peptide therapies, the non-therapeutic status of Melanotan 1 (MT1) means it is not legally available through these platforms. For FDA-approved peptides, telehealth clinics often bundle consultation and medication into a single cost, which can provide convenience and potential savings.

Ways to Reduce Cost

Since Melanotan 1 (MT1) is not legally available for personal use, cost reduction strategies are not applicable. For those seeking legal peptide therapies, consider manufacturer savings programs, patient assistance programs, or discount tools like GoodRx, which may offer savings on FDA-approved medications.

Cost Compared to Alternatives

For those interested in peptide therapies for pigmentation, FDA-approved alternatives like afamelanotide, which is approved for specific conditions like erythropoietic protoporphyria, may be considered. While afamelanotide is typically more expensive, it offers legal and insurance-covered options for eligible patients.

What to Ask Your Provider About Cost

When discussing peptide therapies with your healthcare provider, consider asking:

• Are there any FDA-approved peptides that could address my needs?
• What are the potential costs associated with alternative treatments?
• Are there any patient assistance programs available for these therapies?
• How can I verify if a peptide is legally available for therapeutic use?

FAQ

Q: Is Melanotan 1 (MT1) covered by insurance?
A: No, MT1 is not covered by insurance as it is not FDA-approved for therapeutic use.

Q: Can I use HSA/FSA funds to purchase Melanotan 1 (MT1)?
A: No, MT1 does not qualify for HSA/FSA spending because it is not an FDA-approved medication.

Q: How can I legally obtain Melanotan 1 (MT1)?
A: MT1 can only be obtained for research purposes through authorized suppliers and is not available for personal use in the US.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.